Following a decision taken by the Ministry of Higher Education and Research, Syncrosome has been awarded the authorization of « Crédit Impôt Recherche » in France (Research Credit). This authorization is accorded for the years 2019, 2020 and 2021. The French Ministry thereby recognizes that Syncrosome is a fully...
The participation to the « Spring of Cardiology » offered to Syncrosome the opportunity to present its expertise in the cardiovascular field: development of preclinical models of heart failure and evaluation of cardiac remodelling and function by 2D-echocardiography to assess the efficacy of new therapeutic strategies. Since 2016,...
The 19th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. The #Sachs_BEF19 forum will be held for the sixth time in Basel to be close to the largest biopharma hub in...
Syncrosome at Bio2019 Come and meet Syncrosome at #BIO2019 booth #2109. Syncrosome invites you to visit us at BioConvention, June 3rd to June 7th 2016, in Philadelphia, USA. Emmanuelle Bettendorf, our Account Manager would be delighted to meet you their and discuss your in vivo preclinical projects. We...
SYNCROSOME your dedicated partner for In Vivo Efficacy Studies has been accepted for a poster presentation at NeuroFrance 2019 (Marseille, France, 22-24 May) which is an International Meeting from Société des Neurosciences. Thanks to its CNS expertise our CNS Study Monitor, Dr. Delphine Revy, will present several...
See you soon in Rotterdam (20-22 May, 2019) to exchange on Gastrointestinal, Cardiovascular and Central Nervous System diseases.Let's stay tuned and we will give you more details on our talk, booth and possibility to meet their! ...
As you know Syncrosome is a preclinical CRO managing efficacy in vivo/ in vitro studies with more than 15 disease models validated in house and highly reproducible. Syncrosome is involved in Central Nervous System activities for 16 years with a specific department dedicated to several CNS...
We wish you Health, Happiness and Prosperity throughout the New year!! ...
The 6ThDrug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Frankfurt (Germany) from 29 to 30thof October. This conference will offer a complete programme focusing on preclinical animal models, breakthrough technologies : Target engagement Advances in medicinal...
Multiple studies have been performed to evaluate the effects of mesenchymal stem cells (MSCs) in preclinical Parkinson models. We performed a meta-analysis to estimate the treatment effect of unmodified MSCs on behavioral outcomes in preclinical studies of Parkinson's disease (PD). We performed a systematic literature search...